AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21463139
Drug: Docetaxel-based therapy
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel-based therapy
Trial: 21192296
Drug: Standard exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard exercise therapy
Trial: 9327311
Drug: fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: fentanyl infusion + diazepam + sodium nitroprusside (SNP)
Trial: 9327311
Drug: fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: fentanyl infusion + isoflurane
Trial: 9327311
Drug: fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: fentanyl infusion + diazepam
Trial: 7968323
Drug: Vecuronium with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium with a priming dose of 0.1 mg/kg followed by 0.09 mg/kg (Gp1)
Trial: 7968323
Drug: Vecuronium with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium with a priming dose of 0.1 mg/kg followed by 0.14 mg/kg (Gp2)
Trial: 7968323
Drug: Vecuronium with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium with a priming dose of 0.1 mg/kg followed by 0.19 mg/kg (Gp3)
Trial: 7968323
Drug: Vecuronium without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium without a priming dose followed by 0.1 mg/kg (Gp4)
Trial: 7968323
Drug: Vecuronium without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium without a priming dose followed by 0.15 mg/kg (Gp5)
Trial: 7968323
Drug: Vecuronium without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium without a priming dose followed by 0.2 mg/kg (Gp6)
Trial: 28190719
Drug: Three-component smoking
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-component smoking cessation intervention (physician advice, nicotine replacement therapy, and telephone-based quitline referral)
Trial: 26227096
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg linezolid infusion over 0.5 hours
Trial: 26227096
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg linezolid infusion over 2 hours
Trial: 26227096
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg linezolid infusion over 4 hours
Trial: 24119833
Drug: Lorazepam 2
RxNorm normalized name: lorazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 2 mg by mouth
Trial: 21091391
Drug: Prolonged-release melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release melatonin (PRM; Circadin 2 mg)
Trial: 19176534
Drug: Antepartum continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antepartum continuous epidural therapy (ACET) with 0.04, 0.06, 0.08, and 0.1% ropivacaine at 10 ml h(‐1) for 24 h.
Trial: 19176534
Drug: Antepartum continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antepartum continuous epidural therapy (ACET) with 0.1% ropivacaine until delivery.
Trial: 18173095
Drug: OP-lycopene (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OP-lycopene (8 mg lycopene/day for 2 weeks)
Trial: 18173095
Drug: non-OP-lycopene (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: non-OP-lycopene (8 mg lycopene/day for 2 weeks)
Trial: 15469204
Drug: Quetiapine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (50 mg/day titrated to 500 mg/day, maintained or increased to 750 mg/day)
Trial: 12804167
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy (specifics not provided)
Trial: 2181623
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg cimetidine twice daily
Trial: 2096128
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg cimetidine once daily (bedtime)
Trial: 25335860
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of netazepide and rabeprazole
Trial: 21258269
Drug: Depressive symptoms
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depressive symptoms and drug use before sex
Trial: 19681775
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids solution (Control Group)
Trial: 15479889
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care physical therapy (UC)
Trial: 7605232
Drug: Quinidine (QG)
DrugBank: Quinidine (DB00908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinidine (QG) - i.v. digital + quinidine up to 600 mg
Trial: 7605232
Drug: Procainamide (PG)
RxNorm normalized name: PG-530742
DrugBank: Procainamide (DB01035)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Procainamide (PG) - i.v. digital + i.v. procainamide, 10 mg/kg
Trial: 7605232
Drug: Amiodarone (AG)
DrugBank: Amiodarone (DB01118)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amiodarone (AG) - i.v. amiodarone, 5 mg/kg
Trial: 30207488
Drug: Enzalutamide after
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide after chemotherapy
Trial: 30207488
Drug: Enzalutamide after
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide after chemotherapy in abiraterone-pretreated patients
Trial: 30207488
Drug: Enzalutamide after
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide after chemotherapy in abiraterone-naive patients
Trial: 18573775
Drug: Self-administered decision
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered decision aid (DA) booklet about outcomes of biennial faecal occult blood testing (FOBT) screening
Trial: 18573775
Drug: Government consumer
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Government consumer guidelines (G)
Trial: 18573775
Drug: Self-administered decision
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered decision aid (DA)
Trial: 10678548
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg once daily (group 1)
Trial: 10678548
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg once daily plus benazepril 5 or 10 mg once daily (group 2)
Trial: 10678548
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg once daily plus benazepril 5 or 10 mg once daily (group 3)
Trial: 19663597
Drug: Paromomycin 11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paromomycin 11 mg/kg/day for 14 days (Group A)
Trial: 19663597
Drug: Paromomycin 11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paromomycin 11 mg/kg/day for 21 days (Group B)
Trial: 16728716
Drug: Low-dose ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose ethanol (0.5 g/kg body weight per day)
Trial: 16728716
Drug: Morphine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (15 mug/kg body weight per hour)
Trial: 16728716
Drug: Ketoconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200 mg four times daily)
Trial: 15298657
Drug: Paroxetine 20-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20-50 mg/day
Trial: 11736682
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg ropivacaine
Trial: 11736682
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg ropivacaine
Trial: 11736682
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg ropivacaine
Trial: 11736682
Drug: 1-3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-3 mg/kg ropivacaine
Trial: 8564629
Drug: Salmeterol, 50
RxNorm normalized name: Fluticasone-Salmeterol, 500 mcg-50 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol, 50 micrograms, dry powder inhalation
Trial: 31208690
Drug: MoodKit (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MoodKit (active control cognitive-behavioral therapy-based mobile app)
Trial: 31208690
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU; no app)
Trial: 23691965
Drug: SNRI compounds
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SNRI compounds
Trial: 19140909
Drug: Dofetilide therapy
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dofetilide therapy
Trial: 2166142
Drug: Cyclophosphamide, doxorubicin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy
Trial: 2166142
Drug: Vindesine and
RxNorm normalized name: vindesine
DrugBank: Vindesine (DB00309)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindesine and cisplatin (VP) chemotherapy
Trial: 364409
Drug: Levamisole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (150 mg per day for 2 months)
Trial: 28949973
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone pessaries (100 mg)
Trial: 21839850
Drug: Olodaterol 2
RxNorm normalized name: OLODATEROL 2.5MCG/ACTUAT 14D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olodaterol 2 μg
Trial: 24966672
Drug: Olodaterol 5
RxNorm normalized name: Olodaterol
DrugBank: Olodaterol (DB09080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olodaterol 5 μg
Trial: 24966672
Drug: Olodaterol 10
RxNorm normalized name: Olodaterol
DrugBank: Olodaterol (DB09080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olodaterol 10 μg
Trial: 21839850
Drug: Olodaterol 20
RxNorm normalized name: Olodaterol
DrugBank: Olodaterol (DB09080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olodaterol 20 μg
Trial: 19884816
Drug: Pantoprazole, clarithromycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole, clarithromycin, and amoxicillin (PCA) for 14 days
Trial: 19884816
Drug: Ranitidine-bismuth citrate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine-bismuth citrate, clarithromycin, and amoxicillin (RCA) for 14 days
Trial: 17265148
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of olanzapine
Trial: 11224891
Drug: High-dose methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methylprednisolone sodium succinate (MPSS)
Trial: 3085698
Drug: Nitradisc 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitradisc 32 mg patch
Trial: 3085698
Drug: Transiderm‐Nitro 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transiderm‐Nitro 50 mg patch
Trial: 3085698
Drug: Nitro-Dur 104
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitro-Dur 104 mg patch
Trial: 3085698
Drug: Nitrobid 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrobid 2% ointment
Trial: 29732536
Drug: Cognitive-Behavioral Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Treatment of Insomnia (CBTi)
Trial: 24513113
Drug: 0F-200 (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0F-200 (no fluoride in 200 ml milk)
Trial: 24513113
Drug: 1.5F-100 (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5F-100 (1.5 mg fluoride in 100 ml milk)
Trial: 24513113
Drug: 3F-100 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3F-100 (3 mg fluoride in 100 ml milk)
Trial: 24513113
Drug: 1.5F-200 (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5F-200 (1.5 mg fluoride in 200 ml milk)
Trial: 24513113
Drug: 3F-200 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3F-200 (3 mg fluoride in 200 ml milk)
Trial: 24513113
Drug: Fluoride in
RxNorm normalized name: sulfur hexafluoride intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride in 100 ml milk
Trial: 24513113
Drug: All fluoridated
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All fluoridated milk treatments
Trial: 22934395
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection of autologous blood (2 mL/acupoint, once a week for 4 weeks)
Trial: 22934395
Drug: Motilium (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motilium (10 mg, 3 times daily for 4 weeks)
Trial: 22934395
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection of autologous blood
Trial: 17599483
Drug: Strict glycemic
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict glycemic control protocol (insulin administration)
Trial: 15595583
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural anaesthesia with bupivacaine 0.25% and sufentanil 0.001 mg/mL
Trial: 11757212
Drug: Intravenous propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propafenone (bolus of 70 to 140 mg)
Trial: 11757212
Drug: Oral propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propafenone (300 to 600 mg)
Trial: 8059021
Drug: Verapamil (V)
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Verapamil (V) 80 mg/8 h per os before surgery and 5 mg/4-6 h slow infusion during the next intra- and postoperative 24-36 h
Trial: 6313597
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of acyclovir (400 to 1200 mg/m2/dose)
Trial: 6313597
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acyclovir and human alpha interferon (2 to 40 X 10(4) units/kg/day)
Trial: 28248690
Drug: Massage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage treatment (12 twice-weekly 45-min sessions focusing on trigger point release)
Trial: 17908625
Drug: Brief chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief chemotherapy and involved-field radiation
Trial: 17908625
Drug: Brief chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief chemotherapy alone
Trial: 16296963
Drug: Alcohol/chlorhexidine hand
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol/chlorhexidine hand hygiene solution (ACHRS)
Trial: 11937123
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (embryo transfer without any supportive therapy)
Trial: 9742523
Drug: IL-2 7
RxNorm normalized name: IL-7
DrugBank: Interleukin-7 (DB11997)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-2 7 x 10(5) U, 5-fluorouracil (5-FU) 250 mg/day continuous infusion, mitomycin C (MMC) 4 mg once weekly for unresectable liver metastases
Trial: 9742523
Drug: IL-2 1.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-2 1.4 to 2.1 x 10(6) U, 5-FU 250 mg, MMC 2 to 4 mg weekly for 6 months for resectable liver metastases
Trial: 2684552
Drug: Ceftriaxone, 2g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone, 2g IV once daily
Trial: 2684552
Drug: Cefotaxime, 2g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime, 2g IV thrice daily
Trial: 866797
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg of stilbestrol daily
Trial: 24060817
Drug: Iodixanol 320
RxNorm normalized name: IODIXANOL 320mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 320 mg I/mL
Trial: 28045670
Drug: Iopamidol 370
RxNorm normalized name: iopamidol 370 mg iodine/mL (76 %) INTRAVEN KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol 370 mg I/mL
Trial: 20937606
Drug: telcagepant 150
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telcagepant 150 mg
Trial: 10214535
Drug: zolmitriptan 5
RxNorm normalized name: zolmitriptan 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zolmitriptan 5 mg
Trial: 20937606
Drug: telcagepant 300
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telcagepant 300 mg vs zolmitriptan
Trial: 19536906
Drug: Dasatinib 70
RxNorm normalized name: dasatinib 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib 70 mg twice daily (n=101)
Trial: 19536906
Drug: High-dose imatinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose imatinib 800 mg (n=49)
Trial: 15385371
Drug: 0.25% levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% levobupivacaine 12.5 mg/h (5 mL/h)
Trial: 15385371
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 5 mL/h via a catheter
Trial: 1838978
Drug: Clarithromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (250 mg twice daily for 10 days)
Trial: 7998667
Drug: Budesonide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (400 micrograms/day, administered twice daily)
Trial: 7998667
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (DSCG) (31.2 mg/day, administered six times per day)
Trial: 6399346
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium therapy
Trial: 31486166
Drug: High coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High coffee intake (>6 cups daily)
Trial: 25497115
Drug: Sodium benzoate
RxNorm normalized name: Sodium Benzoate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium benzoate (GRAS dose)
Trial: 24481930
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 75 μg with bupivacaine
Trial: 24481930
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine 150 μg with bupivacaine
Trial: 12757449
Drug: Herbal supplements
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal supplements (23 commonly used)
Trial: 1622642
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg daily for 2 years
Trial: 20225908
Drug: Ketoprofen 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 0.25 mg/kg
Trial: 20225908
Drug: Ketoprofen 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 0.5 mg/kg
Trial: 20225908
Drug: Ketoprofen 1
RxNorm normalized name: ketoprofen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 1 mg/kg
Trial: 10100174
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein (single dose, 20 g, 34 mg phytoestrogens)
Trial: 10100174
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein (twice-daily, 20 g, 34 mg phytoestrogens)
Trial: 1687055
Drug: Long-acting GnRHa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting GnRHa (D-Trp-6-LHRH) microcapsules administered intramuscularly at menstruation
Trial: 1687055
Drug: FSH and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSH and hMG from day 3 of the cycle without GnRHa pre-treatment
Trial: 6475827
Drug: Commercial ergogenic
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial ergogenic supplement (vitamin, mineral, amino acid, and unsaturated fatty acid complex) administered at a dose of three capsules daily for 4 weeks.
Trial: 6475827
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered for 4 weeks.
Trial: 20862645
Drug: Pharmacological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatments (modulation of the glutamate system, blocking of serotonin 5-HT-3/2a receptors)
Trial: 18173155
Drug: Lin'erlai Prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lin'erlai Prescription (LEL)
Trial: 16089148
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of xiaoke shen'an capsule and conventional western medicine
Trial: 11994935
Drug: Standardized verbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized verbal administration of GDS-SF
Trial: 11994935
Drug: Non-standardized verbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-standardized verbal administration of GDS-SF